Baricinix 4 mg is an pharmaceutical product indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have not adequately responded to, or are intolerant to one or more disease-modifying anti-rheumatic drugs. It can be used either as a standalone treatment or in combination with Methotrexate.

Product Details:

Product Name : Baricinix

Generic Name : Baricitinib

Formulation : Tablet

Pack Size : 30 tablets per bottle

Available Strengths : 2mg and 4mg

Registrations : Export Only